| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A discrete-choice experiment to determine patient preferences for injectable multiple sclerosis treatments in Germany
|
Poulos, Christine
|
|
2016
|
|
2 |
p. 95-104
|
artikel
|
| 2 |
4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review
|
Jensen, Henrik Boye
|
|
2014
|
|
2 |
p. 97-113
|
artikel
|
| 3 |
A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing–remitting multiple sclerosis
|
Zivadinov, Robert
|
|
2015
|
|
2 |
p. 59-70
|
artikel
|
| 4 |
A preclinical trial of sialic acid metabolites on distal myopathy with rimmed vacuoles/ hereditary inclusion body myopathy, a sugar-deficient myopathy: a review
|
Malicdan, May Christine V.
|
|
2010
|
|
2 |
p. 127-135
|
artikel
|
| 5 |
A review of the use of frovatriptan in the treatment of menstrually related migraine
|
Allais, Gianni
|
|
2013
|
|
2 |
p. 55-67
|
artikel
|
| 6 |
Best practice in the use of natalizumab in multiple sclerosis
|
Fernández, Óscar
|
|
2013
|
|
2 |
p. 69-79
|
artikel
|
| 7 |
Botulinum toxin in the management of blepharospasm: current evidence and recent developments
|
Hellman, Amy
|
|
2015
|
|
2 |
p. 82-91
|
artikel
|
| 8 |
Botulinum toxin in the management of chronic migraine: clinical evidence and experience
|
Escher, Claus M
|
|
2017
|
|
2 |
p. 127-135
|
artikel
|
| 9 |
Challenges in developing new multiple sclerosis therapies
|
Racke, Michael K.
|
|
2008
|
|
2 |
p. 63-65
|
artikel
|
| 10 |
Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case–control studies
|
Tsivgoulis, Georgios
|
|
2014
|
|
2 |
p. 114-136
|
artikel
|
| 11 |
Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis
|
Voss, Elke
|
|
2011
|
|
2 |
p. 123-134
|
artikel
|
| 12 |
Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis
|
Pierrot-Deseilligny, Charles
|
|
2013
|
|
2 |
p. 81-116
|
artikel
|
| 13 |
Current and future treatment approaches for neuromyelitis optica
|
Collongues, Nicolas
|
|
2011
|
|
2 |
p. 111-121
|
artikel
|
| 14 |
Editorial: Challenges in developing new multiple sclerosis therapies
|
Racke, Michael K.
|
|
2008
|
|
2 |
p. 63-65
|
artikel
|
| 15 |
Emerging strategies in the management of essential tremor
|
Hedera, Peter
|
|
2017
|
|
2 |
p. 137-148
|
artikel
|
| 16 |
Erratum
|
|
|
2008
|
|
2 |
p. 143
|
artikel
|
| 17 |
Erratum
|
|
|
2008
|
|
2 |
p. 143-143
|
artikel
|
| 18 |
Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis?
|
Dalgas, Ulrik
|
|
2012
|
|
2 |
p. 81-95
|
artikel
|
| 19 |
Fingolimod in the treatment of relapsing–remitting multiple sclerosis: long-term experience and an update on the clinical evidence
|
Khatri, Bhupendra O.
|
|
2016
|
|
2 |
p. 130-147
|
artikel
|
| 20 |
Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease
|
Greenberg, Steven J.
|
|
2016
|
|
2 |
p. 105-117
|
artikel
|
| 21 |
From injection therapies to natalizumab: views on the treatment of multiple sclerosis
|
Bomprezzi, Roberto
|
|
2012
|
|
2 |
p. 97-104
|
artikel
|
| 22 |
Health-related quality of life as an outcome variable in Parkinson’s disease
|
Martinez-Martin, Pablo
|
|
2012
|
|
2 |
p. 105-117
|
artikel
|
| 23 |
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany
|
Stroet, Anke
|
|
2012
|
|
2 |
p. 75-79
|
artikel
|
| 24 |
Management of epilepsy during pregnancy: an update
|
Patel, Sima I.
|
|
2016
|
|
2 |
p. 118-129
|
artikel
|
| 25 |
Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis
|
Berkovich, Regina
|
|
2014
|
|
2 |
p. 83-96
|
artikel
|
| 26 |
Neurocysticercosis
|
Singhi, Pratibha
|
|
2011
|
|
2 |
p. 67-81
|
artikel
|
| 27 |
Neuroimaging of motor neuron diseases
|
Kassubek, Jan
|
|
2012
|
|
2 |
p. 119-127
|
artikel
|
| 28 |
New treatment option for partial-onset seizures: efficacy and safety of lacosamide
|
Chung, Steve S.
|
|
2010
|
|
2 |
p. 77-83
|
artikel
|
| 29 |
Nontraumatic spinal cord injury at the neurological intensive care unit: spectrum, causes of admission and predictors of mortality
|
Grassner, Lukas
|
|
2016
|
|
2 |
p. 85-94
|
artikel
|
| 30 |
Outcome and periprocedural time management in referred versus directly admitted stroke patients treated with thrombectomy
|
Weber, Ralph
|
|
2016
|
|
2 |
p. 79-84
|
artikel
|
| 31 |
Pharmacotherapy in Parkinson’s disease: case studies
|
Mestre, Tiago
|
|
2010
|
|
2 |
p. 117-126
|
artikel
|
| 32 |
Practical considerations on the use of rituximab in autoimmune neurological disorders
|
Kosmidis, Mixalis L.
|
|
2010
|
|
2 |
p. 93-105
|
artikel
|
| 33 |
Prothrombotic risk factors and antithrombotic therapy in children with ischemic stroke
|
Eltayeb, Azza A.
|
|
2015
|
|
2 |
p. 71-81
|
artikel
|
| 34 |
Recent advances in the management of choreas
|
Burgunder, Jean-Marc
|
|
2013
|
|
2 |
p. 117-127
|
artikel
|
| 35 |
Recent advances in the treatment of familial amyloid polyneuropathy
|
Adams, David
|
|
2013
|
|
2 |
p. 129-139
|
artikel
|
| 36 |
Review: Diagnosis and treatment of paroxysmal dyskinesias revisited
|
Unterberger, Iris
|
|
2008
|
|
2 |
p. 67-74
|
artikel
|
| 37 |
Review: Diagnosis and treatment of paroxysmal dyskinesias revisited
|
Unterberger, Iris
|
|
2008
|
|
2 |
p. 67-74
|
artikel
|
| 38 |
Review: Natalizumab in the treatment of multiple sclerosis
|
Yaldizli, Özgür
|
|
2009
|
|
2 |
p. 115-128
|
artikel
|
| 39 |
Review: Neutralizing antibodies against interferon-beta
|
Soelberg Sorensen, Per
|
|
2008
|
|
2 |
p. 125-141
|
artikel
|
| 40 |
Review: Neutralizing antibodies against interferon-beta
|
Soelberg Sorensen, Per
|
|
2008
|
|
2 |
p. 125-141
|
artikel
|
| 41 |
Review: New advances in the treatment of neurological diseases using high dose intravenous immunoglobulins
|
Stangel, Martin
|
|
2008
|
|
2 |
p. 115-124
|
artikel
|
| 42 |
Review: New advances in the treatment of neurological diseases using high dose intravenous immunoglobulins
|
Stangel, Martin
|
|
2008
|
|
2 |
p. 115-124
|
artikel
|
| 43 |
Review: New treatment options in status epilepticus: a critical review on intravenous levetiracetam
|
Trinka, Eugen
|
|
2009
|
|
2 |
p. 79-91
|
artikel
|
| 44 |
Review: Primary CNS lymphoma
|
Schlegel, Uwe
|
|
2009
|
|
2 |
p. 93-104
|
artikel
|
| 45 |
Review: Progress in the treatment of myasthenia gravis
|
Gold, Ralf
|
|
2008
|
|
2 |
p. 99-114
|
artikel
|
| 46 |
Review: Progress in the treatment of myasthenia gravis
|
Gold, Ralf
|
|
2008
|
|
2 |
p. 99-114
|
artikel
|
| 47 |
Review: Therapeutic applications of hypothermia in cerebral ischaemia
|
Meloni, Bruno P.
|
|
2008
|
|
2 |
p. 75-98
|
artikel
|
| 48 |
Review: Therapeutic applications of hypothermia in cerebral ischaemia
|
Meloni, Bruno P.
|
|
2008
|
|
2 |
p. 75-98
|
artikel
|
| 49 |
Review: Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease
|
Sujith, O.K.
|
|
2009
|
|
2 |
p. 105-113
|
artikel
|
| 50 |
Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner
|
Oreja-Guevara, Celia
|
|
2014
|
|
2 |
p. 137-149
|
artikel
|
| 51 |
Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing—remitting multiple sclerosis: 2-year results from the COGIMUS study
|
Patti, Francesco
|
|
2009
|
|
2 |
p. 67-77
|
artikel
|
| 52 |
Symptomatic therapy in multiple sclerosis
|
Frohman, Teresa C.
|
|
2011
|
|
2 |
p. 83-98
|
artikel
|
| 53 |
Tetrabenazine in treatment of hyperkinetic movement disorders: an observational study
|
Miguel, Rita
|
|
2017
|
|
2 |
p. 81-90
|
artikel
|
| 54 |
The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experience
|
Bauer, Sebastian
|
|
2017
|
|
2 |
p. 103-126
|
artikel
|
| 55 |
The emerging role of tacrolimus in myasthenia gravis
|
Cruz, Jennifer L.
|
|
2015
|
|
2 |
p. 92-103
|
artikel
|
| 56 |
Tolcapone addition improves Parkinson’s disease associated nonmotor symptoms
|
Müller, Thomas
|
|
2014
|
|
2 |
p. 77-82
|
artikel
|
| 57 |
Treating epilepsy across its different stages
|
Beghi, Ettore
|
|
2010
|
|
2 |
p. 85-92
|
artikel
|
| 58 |
Treatment of walking impairment in multiple sclerosis with dalfampridine
|
Blight, Andrew R.
|
|
2011
|
|
2 |
p. 99-109
|
artikel
|
| 59 |
Treatment options in trigeminal neuralgia
|
Obermann, Mark
|
|
2010
|
|
2 |
p. 107-115
|
artikel
|
| 60 |
Two years’ long-term follow up in chronic inflammatory demyelinating polyradiculoneuropathy: efficacy of intravenous immunoglobulin treatment
|
Ellrichmann, Gisa
|
|
2017
|
|
2 |
p. 91-101
|
artikel
|
Tijdschrift beschrijving